Results 51 to 60 of about 6,369 (156)

Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.
ABSTRACT Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health ...
Judit Riera‐Arnau   +62 more
wiley   +1 more source

Recombinant human granulocyte colony stimulating factor versus bone marrow mononuclear cells in treatment of pulmonary emphysema model

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2017
Background: Stem cells therapy is a new therapeutic approach for pulmonary emphysema. Granulocyte colony-stimulating factor (G-CSF) is effective in tissue regeneration through mobilization of stem cells to different organs.
Mohammad K. El-badrawy   +8 more
doaj   +1 more source

Development and certification of an industrial reference standard for determination of filgrastim activity

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
The article provides with the information on certification of an industrial reference standard (IRS) for determination of filgrastim activity. In order to confirm the quality of the IRS candidate, the following tests have been performed: biological ...
E. V. Motuzova   +9 more
doaj  

Biosimilars in the management of neutropenia: focus on filgrastim

open access: yesBiologics: Targets & Therapy, 2016
Désirée Caselli,1 Simone Cesaro,2 Maurizio Aricò1 1Medical Department, Pediatric Unit, Azienda Sanitaria Provinciale Ragusa, Ragusa, 2Department of Pediatrics, Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria ...
Caselli D, Cesaro S, Aricò M
doaj  

Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities

open access: yesBMC Cancer, 2004
Background Patients with cancer must make frequent visits to the clinic not only for chemotherapy but also for the management of treatment-related adverse effects.
Moore Kelley   +6 more
doaj   +1 more source

Pancytopenia following rituximab therapy in a patient with rheumatoid arthritis: Could filgrastim be a temporary solution?

open access: yesAsian Journal of Medical Sciences, 2016
Rheumatoid arthritis is a chronic inflammatory disease affecting the peripheral joints and can also have extraarticular manifestations.
Robin George Manappallil
doaj   +1 more source

Quantification of the cellular content of platelet-rich plasma harvested after injection of filgrastim versus pegfilgrastim biosimilars: a prospective, single-center, crossover study

open access: yesJournal of Cartilage & Joint Preservation
Introduction: Hematopoietic stem cells (HSCs) appear in peripheral blood (PB) following mobilization due to external events or pharmaceutical agents like filgrastim and pegfilgrastim.
Mohammadreza Abbasian   +6 more
doaj   +1 more source

Toxic epidermal necrolysis in hemodialysis patient

open access: yesAdvanced Biomedical Research, 2015
Toxic epidermal necrolysis (TEN) is a rare and life-threatening allergic drug reaction. We report a 26-year-old young female with end-stage renal disease on maintenance hemodialysis developing TEN while on filgrastim and phenytoin.
Uday Venkat Mateti   +5 more
doaj   +1 more source

Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia

open access: yesPatient Preference and Adherence, 2018
Burkhard Otremba,1 Carsten Hielscher,2 Volker Petersen,3 Christian Petrik4 1Oncological Practice Oldenburg/Delmenhorst, Oldenburg, Germany; 2Gynecology Competence Center Stralsund, Stralsund, Germany; 3Practice for Hematology and Oncology, Heidenheim ...
Otremba B   +3 more
doaj  

Erythema multiforme secondary to filgrastim in a case of pemphigus vulgaris

open access: yesMuller Journal of Medical Sciences and Research
Erythema multiforme (EM) is an acute inflammatory mucocutaneous disorder which can be triggered by host of factors including drugs. Filgrastim is a Granulocyte Colony-Stimulating Factor (G-CSF) analogue used to stimulate the production of white blood ...
Prachi Bhandare   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy